Filter
868
Text search:
mental
disorders
Featured
Recommendations
110
New Publications
133
Language
Document type
No document type
544
Studies & Reports
104
Guidelines
102
Manuals
38
Training Material
21
Strategic & Response Plan
21
Fact sheets
18
Situation Updates
6
Resource Platforms
6
Brochures
5
Infographics
3
Countries / Regions
Global
38
India
36
Western and Central Europe
25
South Africa
17
Ethiopia
15
Kenya
15
Eastern Europe
14
Nigeria
13
Ukraine
13
Germany
12
Latin America and the Carribbean
12
Nepal
11
Syria
11
Sierra Leone
8
Ghana
8
Rwanda
8
Malawi
8
Africa
8
Bangladesh
7
South–East Asia Region
7
Philippines
6
Russia
6
Liberia
5
Mozambique
5
Asia
5
Uganda
4
South Sudan
4
Tanzania
4
Cambodia
4
Namibia
4
Brazil
4
Myanmar / Burma
4
Congo, Democratic Republic of
3
USA
3
Eswatini/ Swaziland
3
Lesotho
3
Zimbabwe
2
Zambia
2
Indonesia
2
Sudan
2
Sri Lanka
2
Yemen
2
Middle East and North Africa
2
Western Pacific Region
2
Estonia
2
United Kingdom
2
Guinea
1
Guinea-Bissau
1
Niger
1
Togo
1
Haiti
1
Iraq
1
Jordan
1
Afghanistan
1
Turkey
1
Egypt
1
China
1
Papua New Guinea
1
Peru
1
Hungary
1
Botswana
1
El Salvador
1
Bolivia
1
Angola
1
West and Central Africa
1
Eastern Europe and Central Asia
1
Paraguay
1
Venezuela
1
Poland
1
Albania
1
Laos
1
Canada
1
Tajikistan
1
Lithuania
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Authors & Publishers
Publication Years
Category
Countries
204
Public Health
51
Clinical Guidelines
51
Women & Child Health
37
Key Resources
27
Capacity Building
17
Annual Report MEDBOX
1
Pharmacy & Technologies
1
Toolboxes
Mental Health
354
Disability
51
COVID-19
50
HIV
38
Refugee
31
Caregiver
24
Conflict
23
NCDs
23
Planetary Health
21
Global Health Education
12
Pharmacy
11
TB
10
NTDs
8
Natural Hazards
7
Ebola & Marburg
6
Zika
6
Specific Hazards
4
Rapid Response
3
AMR
3
Social Ethics
2
2.0 Rapid Response
2
Cholera
1
Health Financing Toolbox
1
Otros trastornos
Capítulo H.4
Editores: Laura Borredá Belda, Matías Irarrázaval & Andres Martin
Traductores: Sara Diego Castaño, Laura Álvarez Bravos, Rebeca Santonja & Beatriz Ortega
Autres troubles
Chapitre H.4
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?
Q 2: How long should treatment with antidepressants continue in adults with depressive episode/disorder?
November 3, 2009https://doi.org/10.1371/journal.pmed.1000176
PLoS Med 6(11): e1000176. https://doi.org/10.1371/journal.pmed.1000176
Q7: What is the effectiveness, safety and role of pharmacological and non-pharmacological interventions, within non- specialist health care for children with a diagnosis of Attention-deficit hyperactivity disorder (ADHD)?
SCOPING QUESTION:Which psychosocial interventions are effective in the treatment of psychostimulant dependence for adults and young people?
Autres troubles
Chapitre H.1
Edition en français
Traduction : Priscille Gérardin et Malaïka Lasfar Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA
Received Date: Jun 15, 2017; Accepted Date: Jun 28, 2017; Published Date: Jun 30, 2017
Citation: Etindele Sosso FA, Nakamura O, Nakamura M (2017) Epidemiology of Alzheimer’s Disease: Comparison between Africa and South America. J Neurol Neurosci Vol.8 No.4:204. DOI: 10.21767/2171-6625.1000204
...
Published: March 28, 2017https://doi.org/10.1371/journal.pmed.1002271
PLoS Med 14(3): e1002271. https://doi.org/10.1371/journal.pmed.1002271
Troubles anxieux
Chapitre F.1
Edition en français Traduction : Jean-Philippe Raynaud Avec le soutien de la SFPEADA
Neurology Asia 2008; 13 : 41 – 48
(2015)
Scoping question: Are antidepressants (specifically, tricyclic antidepressants and selective serotonin reuptake inhibitors) effective and safe in adolescents with moderate-severe depressive disorder for whom psychosocial interventions have proven ineffective?
Autres troubles
Chapitre H.5
Edition en français Traduction : Bojan Mirkovic Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an
...